BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 10075931)

  • 1. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells.
    Sieweke MH; Tekotte H; Jarosch U; Graf T
    EMBO J; 1998 Mar; 17(6):1728-39. PubMed ID: 9501094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
    Chang CH; Scott GK; Baldwin MA; Benz CC
    Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.
    Hodge DR; Robinson L; Watson D; Lautenberger J; Zhang XK; Venanzoni M; Seth A
    Oncogene; 1996 Jan; 12(1):11-8. PubMed ID: 8552380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
    Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
    Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
    Hamazato F; Fujimura Y; Tamai Y; Takemoto Y; Matsushiro A; Nozaki M
    Biochem Biophys Res Commun; 1993 Apr; 192(2):430-8. PubMed ID: 7683460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
    Lenny N; Meyers S; Hiebert SW
    Oncogene; 1995 Nov; 11(9):1761-9. PubMed ID: 7478604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and functional analysis of the p42Ets-1 variant of the mouse Ets-1 transcription factor.
    Lionneton F; Lelièvre E; Baillat D; Stehelin D; Soncin F
    Oncogene; 2003 Dec; 22(57):9156-64. PubMed ID: 14668797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM; Wurtz JM; Wasylyk B
    EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family.
    Schneikert J; Lutz Y; Wasylyk B
    Oncogene; 1992 Feb; 7(2):249-56. PubMed ID: 1549346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
    De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
    Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation in megakaryocytes: the thrombopoietin receptor gene as a model.
    Mignotte V; Deveaux S; Filipe A
    Stem Cells; 1996; 14 Suppl 1():232-9. PubMed ID: 11012226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Ets function by protein - protein interactions.
    Li R; Pei H; Watson DK
    Oncogene; 2000 Dec; 19(55):6514-23. PubMed ID: 11175367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
    Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
    Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1.
    Santiago FS; Khachigian LM
    Circ Res; 2004 Sep; 95(5):479-87. PubMed ID: 15297375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features.
    Albagli O; Flourens A; Crepieux P; Begue A; Stehelin D; Leprince D
    Oncogene; 1992 Jul; 7(7):1435-9. PubMed ID: 1620554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.